LDS/Medical Tests/HLA-B27 Genotyping for Uveitis

HLA-B27 Genotyping for Uveitis

Uveitis is inflammation of the uvea of the eye, which consists of the middle, pigmented vascular structures of the eye including the iris, ciliary body and choroid. Uveitis can be classified as anterior, intermediate or posterior. Anterior uveitis accounts for ~70-90% of uveitis cases and is characterized by the inflammation of the anterior chamber, iris and ciliary body. This condition can occur as a single episode and subside with proper treatment or may take on a recurrent or chronic nature.

HLA-B27-associated uveitic syndrome is the second commonest cause of anterior uveitis, following idiopathic uveitis. It accounts for 40 to 70% of cases of acute anterior uveitis in different patient populations and has a higher frequency in males than in females. Classically, B27-associated uveitis presents with sudden onset of acute anterior uveitis in a young patient. It starts in one eye but is usually asymmetrically bilateral. Studies show that it is also associated with higher recurrence rates than the idiopathic variety.

Uveitis associated with the HLA-B27 gene may occur in the presence or absence of other associated systemic conditions such as ankylosing spondylitis or other spondyloarthropathies; some patients may present with the ocular symptoms as the first manifestation of a systemic condition that may declare itself later. Most patients have an associated systemic disease, and many of those are undiagnosed at the time of first episode of uveitis.

Patients with recurrent anterior uveitis and the absence of a clear etiology should be tested for HLA-B27 because of its prognostic implications and because it may help in therapeutic planning. Patients who give a history suggestive of a spondyloarthropathy should be tested for the HLA-B27 gene irrespective of the location of the uveitis and the number of episodes.

  • Diagnosis of HLA-B27-associated uveitis
  • Prognosis and treatment of anterior uveitis
  • Risk assessment for HLA-B27-associated spondyloarthropathies and systemic disease
  • The presence of HLA-B27 in a patient with uveitic symptoms is usually associated with a good prognosis. Atypical HLA-B27-associated uveitis may have a poor prognosis with more severe inflammation, more recurrences, higher complication rate and poor visual outcomes
  • The presence of HLA-B27 may be indicative of an undiagnosed systemic disease or spondyloarthropathy

Negative for HLA-B27 Variation

Polymerase Chain Reaction (PCR)/Sequence-Specific Oligonucleotide Probe (SSO), Polymerase Chain Reaction (PCR)/Sequence Specific Primer Extension, Direct sequencing, Next Generation Sequencing.

Whole blood (ACD yellow top tube is preferred, EDTA lavender top tube also accepted).

Stability

  • Ambient: 5 days
  • Refrigerated: 7 days
Human T-Cell Lymphotropic Virus (HTLV) I/, West Nile Virus, Ankylosing Spondylitis (HLA-B27) Genotyping, Sedirate, CBC, Rheumatoid Arthritis, CRP.
5-10 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login